ADIL expects phase 3 data to arrive 6 months after the last patient was dosed in the trial. This happened on Feb 22, 2022. The date for the catalyst is […]

This goes through the 23rd, it’s a pretty big event where smaller companies get to have an audience to parade around their new products or whatever they want to present […]

This event has MANY more companies than we have listed so far, this one snuck up on us and we are only posting about it a few days before it […]

Nat Gas inventory day is a highly volatile day for any natural gas trade, and for traders who really like to get an adrenalin rush, there are leveraged ETFs and […]

This meeting is to elect two board members, which is no big deal, and then there’s a 3rd measure to lower their capital reserves. That could have an impact on […]

This event is not really promoted, especially as a company event.  We found it in a random calendar online and figured we would add it here, but we are unaware […]

Smaller event, might not be a huge catalyst, depending on the information presented. With less companies attending, that influences the audience in a negative way compared to other events.

Link to PDUFA PR: https://www.businesswire.com/news/home/20211101005269/en/Incyte-Announces-Acceptance-of-NDA-for-Parsaclisib-for-Three-Types-of-Relapsed-or-Refractory-Non-Hodgkin-Lymphomas

When warrants come with a time period where they cannot be exercised, the date that they can exercise is not entirely inconsequential. Hedge Funds like Armistice are in it for the quickest, largest gains they can get-as all hedge funds are. So they are very interested in seeing that price get to .70 so they […]

Nat Gas inventory day is a highly volatile day for any natural gas trade, and for traders who really like to get an adrenalin rush, there are leveraged ETFs and options that can all move aggressively one way or the other due to whether inventory comes in above or below forecast. For traders who like […]

NILE is renown for doing things that catch the attention of FOMO traders and the press, and using those events to run the stock price (or, lets say it happens coincidentally, but consistently coincidentally). Your friends who warn you about this company are not wrong, but there are plenty of things to get excited about […]

This is the date that the Advisory Committee will reconvene to discuss new additions to studies presented in March of this year.  An Ad Com is a RUMOR FUELER, because while they do vote on whether the drug is worth presenting to the FDA, the FDA is not binded to the decision the Ad Com […]